Are JAK inhibitors (specifically tofacitinib or ruxolitinib) an effective treatment option for alopecia areata?
Featuring Seemal Desai, MD | Education Advisor |

Clinical Assistant Professor
Department of Dermatology
University of Texas Southwestern Medical Center
Dallas, TX

| Published April 14, 2021
Loading...
Loading...
Loading...
Dermsquared

The leading platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2023 dermsquared | All Rights Reserved